Cargando…

A Novel Score Combining Magnetic Resonance Spectroscopy Parameters and Systemic Immune-Inflammation Index Improves Prognosis Prediction in Non-Small Cell Lung Cancer Patients With Brain Metastases After Stereotactic Radiotherapy

OBJECTIVE: The aim of this study was to evaluate the prognostic significance of the combination of the magnetic resonance spectroscopy (MRS) parameters and systemic immune-inflammation index (SII) in patients with brain metastases (BMs) from non-small cell lung cancer (NSCLC) treated with stereotact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Dong, Liu, Jiafeng, Li, Yanping, Chen, Qingqing, Zhao, Yunzheng, Guo, Xinwei, Zhu, Shuchai, Ji, Shengjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213835/ https://www.ncbi.nlm.nih.gov/pubmed/35756607 http://dx.doi.org/10.3389/fonc.2022.762230

Ejemplares similares

Brain Metastases of Non-Small Cell Lung Cancer: Magnetic Resonance Spectroscopy for Clinical Outcome Assessment in Patients with Stereotactic Radiotherapy
por: Jia, Congli, et al.
Publicado: (2020)

Evaluation of Predictive Values of Naples Prognostic Score in Patients with Unresectable Stage III Non-Small Cell Lung Cancer
por: Guo, Dong, et al.
Publicado: (2021)

The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy
por: Zhang, Yanan, et al.
Publicado: (2021)

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013)

The impact of radiosensitivity on clinical outcomes of spinal metastases treated with stereotactic body radiotherapy
por: Guo, Lanlan, et al.
Publicado: (2023)

RONC-06. Stereotactic radiosurgery and stereotactic radiotherapy for pediatric brain metastases or recurrences
por: McGovern, Susan, et al.
Publicado: (2022)

Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
por: Xie, Xue-Yi, et al.
Publicado: (2022)

Dose-effect relationship of linear accelerator based stereotactic radiotherapy for brain metastases
por: Wu, Ning, et al.
Publicado: (2023)

Treatment of Sarcoma Lung Metastases with Stereotactic Body Radiotherapy
por: Lindsay, Adam D., et al.
Publicado: (2018)

Systematic Review of the Role of Stereotactic Radiotherapy for Bone Metastases
por: Spencer, Katie L, et al.
Publicado: (2019)

Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases
por: Gutiérrez, Enrique, et al.
Publicado: (2021)

Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?
por: van Dorp, Martijn, et al.
Publicado: (2023)

Simple immobilization for stereotactic radiotherapy aimed at pelvic metastases
por: Janssen, Jorinde, et al.
Publicado: (2023)

Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis
por: Calderon, Benoît, et al.
Publicado: (2023)

Neuroendocrine Carcinoma of Uterine Cervix: Stereotactic Radiotherapy for Brain Metastasis and Stereotactic Body Radiotherapy for Renal and Pancreatic Metastases
por: Mori, Yoshimasa, et al.
Publicado: (2020)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
por: Gutschenritter, Tyler, et al.
Publicado: (2020)

A new prognostic score for predicting survival in patients treated with robotic stereotactic radiotherapy for brain metastases
por: Stankiewicz, Magdalena, et al.
Publicado: (2021)

Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2022)

An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases
por: Ding, Shouliang, et al.
Publicado: (2023)

Stereotactic radiotherapy in epithelial ovarian cancer brain metastases patients
por: Celejewska, Agata, et al.
Publicado: (2014)

Improving accuracy for stereotactic body radiotherapy treatments of spinal metastases
por: Rijken, James, et al.
Publicado: (2018)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases
por: Berkovic, Patrick, et al.
Publicado: (2020)

Predicting the benefit of stereotactic body radiotherapy of colorectal cancer metastases
por: Lindberg, Sara, et al.
Publicado: (2022)

Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases
por: Księżniak-Baran, Dorota, et al.
Publicado: (2015)

Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases
por: Hirata, Masanori, et al.
Publicado: (2022)

Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
por: Jiang, Xue-song, et al.
Publicado: (2012)

Cone-beam computed tomography in hypofractionated stereotactic radiotherapy for brain metastases
por: Ingrosso, Gianluca, et al.
Publicado: (2012)

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Spine Stereotactic Body Radiotherapy Outcomes in Patients with Concurrent Brain Metastases
por: Colaco, Rovel J, et al.
Publicado: (2016)

Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases
por: Combs, Stephanie E., et al.
Publicado: (2018)

Stereotactic body radiotherapy with a single isocentre for multiple pulmonary metastases
por: Nakamura, Ryuji, et al.
Publicado: (2020)

Risk‐adapted stereotactic body radiotherapy for patients with cervical spinal metastases
por: Wang, Huan‐Huan, et al.
Publicado: (2022)

Five-Fraction Stereotactic Radiotherapy for Brain Metastases—A Retrospective Analysis
por: Layer, Julian P., et al.
Publicado: (2023)

Re-Irradiation by Stereotactic Radiotherapy of Brain Metastases in the Case of Local Recurrence
por: Touati, Ruben, et al.
Publicado: (2023)

Fractionated stereotactic radiotherapy of brain metastases: results of a retrospective study
por: Gruber, Isabella, et al.
Publicado: (2023)

Single fraction stereotactic radiosurgery and fractionated stereotactic radiotherapy provide equal prognosis with overall survival in patients with brain metastases at diagnosis without surgery at primary site
por: Ostdiek-Wille, Garett Paul, et al.
Publicado: (2023)

Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
por: Schaule, Jana, et al.
Publicado: (2020)

Correction: Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases
por: Hirata, Masanori, et al.
Publicado: (2023)

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
por: Schaule, Jana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j5s870hf3ma09mepuc13n4hfk6